Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery

• Status: Recruiting
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim is to analyze the effect of intravenous lidocaine administration on postoperative opioid use in patients undergoing upper abdominal cancer surgery. Specifically, those patients undergoing gastric cancer surgery and liver cancer surgery using a laparoscopic approach

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Men and women over 18 years of age scheduled for gastric or liver cancer surgery through a laparoscopic approach at the University of Girona Dr Josep Trueta.

• Accept and sign the informed consent

Exclusion Criteria:

• decline participating in the study at any stage of its development.

• History of allergic or adverse reactions to Amide-type anesthetics.

• Pregnancy or lactation period

• Diagnosis of Child-Pugh stage B or C liver failure.

• Acute renal failure (GFR <60 ml / min).

• Concomitant treatment with opioids for chronic pain.

• Any condition that, in the clinical judgment of the researchers, may interfere with the object of the research.